Medical premiums and the public system
Most of you will have seen the notices advising increased premiums in the last month, ranging from 16% to 22%.
It's been commented for a long time that medical inflation increases at roughly double the inflation rate, but this year, it's significantly more painful. Why?
It's mainly due to market conditions; however, the drivers of premiums aren't always transparent.
The first significant indicator was the public system's failure in 2022 to address the basic...MORE»
Sponsored Content
Southern Cross Health Society Group annual results reflect steep increase in demand for private healthcare
Today Southern Cross Health Society Group (“Group”) shares its annual results for the year ended 30 June 2024, highlighting extraordinary growth in claims over the year; in volume and value. MORE »
Are life advisers expected to recommend the ‘best’ product?Wednesday, May 14th, 9:22AM
[OPINION] Steve Wrights asks whether advisers should recommend the "best" product and asks what is best anyway? MORE» |
What AIA paid out in claims last yearFriday, May 9th, 8:01AM
AIA pays $829.6 million in total claims in 2024. MORE» |
Foundation Life windup plan finally ready for a vote after 7 years
Foundation Life’s shareholders say they “share our policyholders’ frustration” at the time it has taken to finalise a plan to wind up the near $500 million business while giving policyholders choices about whether to take cash, swap for new policies with greater benefits or a combination.
MORE»Cancer claim a chance to forge relationship with client
Financial adviser Tim Fairbrother, of RIVAL Wealth, says a recent claim made by a client who had a cancer diagnosis shows how insurance can take the pressure off in a tough time.
MORE»CoFI: Is this the catalyst for changing service commissions?
The FMA has previously mentioned concern about how the incentives for policy servicing work.
MORE»Gail Costa's farewell message to advisers
In a farewell message to advisers, former Chubb chief executive Gail Costa pays tribute to the work advisers do.
MORE»Non-PHARMAC medicines coverage – aiming for a data-informed evaluation
Non-PHARMAC coverage has become increasingly important to clients purchasing private health insurance, primarily due to rising public demand for treatments and medications not funded by PHARMAC (the government agency overseeing public pharmaceutical purchasing and subsidy).
MORE»